News

The latest news for pharma industry insiders.

Results of the trial suggest that early intervention for intracerebral hemorrhage using parafascicular surgery were safe.

Phase IIa clinical trial of SPG60 for Fragile X syndrome offers hope for disease with no current FDA-approved treatment options.

The latest news for pharma industry insiders.

A difference-in-differences analysis explores the correlation between direct-acting antiviral prescriptions for hepatitis C virus and the softening of state-level limitations.

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

The latest news for pharma industry insiders.

A cohort study digs into whether there is an improvement in overall survival or quality of life within five years of the FDA granting accelerated approval to oncology drugs.

Companies striving for transformed and targeted growth are exploring strategies that include partnerships, artificial intelligence, increased efficiencies, and competitive intelligence.

Wattala warehouse is expected to offer both export consolidation and 3PL services for trade routes that link Africa, Asia, and Europe.

The latest news for pharma industry insiders.

If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.

The collaboration strengthens the capabilities of Tower’s advanced passive temperature-controlled containers.

The acquisition initiates a long-term agreement with Beacon Therapeutics, highlighted by clinical and commercial AAV production.

The latest news for pharma industry insiders.

The program recognizes organizations that prioritize the highest standards of care when it comes to the handling and transportation of goods in the healthcare space.

The new products offer more temperature control and sustainability benefits.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value & Access Advisor, Schoonveld Advisory, offers his thoughts on lower drug prices in the US and provides a sneak peak into future PC features.

The latest news for pharma industry insiders.

The program intends to address pharmacy deserts, which are predominantly found in underserved communities.

The first commercial shipments are scheduled for mid-April.

The latest news for pharma industry insiders.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value and Access Advisor, Schoonveld Advisory and author of The Price of Global Health, explains why pharmaceutical products tend to cost more in the US than the rest of the world.

Although AI has simplified various market access processes, this technology does also present its share of barriers, so what can be done to find a happy medium?

Year-on-year growth in demand is strong, according to the IATA.

The latest news for pharma industry insiders.

Pharma Commerce makes a return trip to Philly for insights on the latest approaches in patient assistance and adherence.

Cohort study examines the potential for spending to significantly decrease for individuals who use these generic versions of biologics.